Hexo needs strategic options to compete in cannabis industry: Activist investor
Activist investor and Riposte Managing Partner Khaled Beydoun explains why he believes Canadian cannabis company Hexo can go higher.
U.S. vs. Canadian cannabis stocks: Key distinctions
Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…
How illegal dispensaries are a threat to the legal cannabis industry
The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
US Officials could be ready to crack down on cannabis craze
Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…
Inside one of the biggest cannabis investor conferences
The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…
How midterm elections could impact the cannabis business
Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…
Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan
Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.
Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC
He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…
Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC
The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…